
Keywords: گنادوتروپین کوریونی بتا انسان; AYA; adolescent and young adult; GCT; germ cell tumor; MOGCT; malignant ovarian germ cell tumor; MaGIC; Malignant Germ Cell Tumor International Consortium; U.S.; United States; U.K.; United Kingdom; CTOs; Clinical Trial Organizations; COG, United States,